New urine test may spot kidney danger before it strikes

NCT ID NCT04864847

Completed Diagnosis Sponsor: Hikari Dx, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new urine test (RENISCHEM L-FABP) to see if it can predict acute kidney injury within 2 days after heart or blood vessel procedures that use contrast dye. Researchers measured a kidney stress marker in 382 adults at higher risk. The goal was to validate the test's ability to catch kidney damage early.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute kidney injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE KIDNEY INJURY CONTRAST-INDUCED NEPHROPATHY

Contacts and locations

Show contact details

Locations

Chandler Regional Medical Center

Chandler, Arizona, 85224, United States
Clearwater Cardiovascular Consultants

Clearwater, Florida, 33756, United States
John Muir Health

Concord, California, 94520, United States
Sinai Hospital of Baltimore

Baltimore, Maryland, 21215, United States
University of Florida at Jacksonville

Jacksonville, Florida, 32209, United States
University of Oklahoma

Oklahoma City, Oklahoma, 73104, United States